Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Chemical profiling of the street cocktail drug 'nyaope' in South Africa using GC-MS II: Stability studies of the cannabinoid, opiate and antiretroviral components during sample storage.

Mthembi PM, Mwenesongole EM, Cole MD.

Forensic Sci Int. 2019 Jul;300:187-192. doi: 10.1016/j.forsciint.2019.04.040. Epub 2019 May 9.

2.

Transforming Ionene Polymers into Efficient Cathode Interlayers with Pendent Fullerenes.

Liu Y, Sheri M, Cole MD, Yu DM, Emrick T, Russell TP.

Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5677-5681. doi: 10.1002/anie.201901536. Epub 2019 Mar 26.

PMID:
30861272
3.

Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples.

Gorlov IP, Pikielny CW, Frost HR, Her SC, Cole MD, Strohbehn SD, Wallace-Bradley D, Kimmel M, Gorlova OY, Amos CI.

BMC Bioinformatics. 2018 Nov 19;19(1):430. doi: 10.1186/s12859-018-2455-0.

4.

Chemical profiling of the street cocktail drug 'nyaope' in South Africa using GC-MS I: Stability studies of components of 'nyaope' in organic solvents.

Mthembi PM, Mwenesongole EM, Cole MD.

Forensic Sci Int. 2018 Nov;292:115-124. doi: 10.1016/j.forsciint.2018.08.001. Epub 2018 Aug 9.

5.

A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases.

Grela A, Gautam L, Cole MD.

Forensic Sci Int. 2018 Nov;292:50-60. doi: 10.1016/j.forsciint.2018.08.034. Epub 2018 Sep 3. Review.

PMID:
30292936
6.

Combining Fullerenes and Zwitterions in Non-Conjugated Polymer Interlayers to Raise Solar Cell Efficiency.

Liu Y, Sheri M, Cole MD, Emrick T, Russell TP.

Angew Chem Int Ed Engl. 2018 Jul 26;57(31):9675-9678. doi: 10.1002/anie.201803748. Epub 2018 Jul 3.

PMID:
29893448
7.

Chemical and Morphological Control of Interfacial Self-Doping for Efficient Organic Electronics.

Liu Y, Cole MD, Jiang Y, Kim PY, Nordlund D, Emrick T, Russell TP.

Adv Mater. 2018 Apr;30(15):e1705976. doi: 10.1002/adma.201705976. Epub 2018 Mar 5.

PMID:
29504157
8.

Voluntary induction and maintenance of alcohol dependence in rats using alcohol vapor self-administration.

de Guglielmo G, Kallupi M, Cole MD, George O.

Psychopharmacology (Berl). 2017 Jul;234(13):2009-2018. doi: 10.1007/s00213-017-4608-7. Epub 2017 Mar 24.

9.

Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation.

Weyburne ES, Wilkins OM, Sha Z, Williams DA, Pletnev AA, de Bruin G, Overkleeft HS, Goldberg AL, Cole MD, Kisselev AF.

Cell Chem Biol. 2017 Feb 16;24(2):218-230. doi: 10.1016/j.chembiol.2016.12.016. Epub 2017 Jan 26.

10.

HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.

Smits NC, Kobayashi T, Srivastava PK, Skopelja S, Ivy JA, Elwood DJ, Stan RV, Tsongalis GJ, Sellke FW, Gross PL, Cole MD, DeVries JT, Kaplan AV, Robb JF, Williams SM, Shworak NW.

Matrix Biol. 2017 Nov;63:69-90. doi: 10.1016/j.matbio.2017.01.003. Epub 2017 Jan 23.

11.

MYC Mediates mRNA Cap Methylation of Canonical Wnt/β-Catenin Signaling Transcripts By Recruiting CDK7 and RNA Methyltransferase.

Posternak V, Ung MH, Cheng C, Cole MD.

Mol Cancer Res. 2017 Feb;15(2):213-224. doi: 10.1158/1541-7786.MCR-16-0247. Epub 2016 Nov 29.

12.

Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk.

Pattison JM, Posternak V, Cole MD.

Mol Cancer Res. 2016 Nov;14(11):1078-1086. Epub 2016 Aug 11.

13.

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, Lophatananon A, Fasching PA, Beckmann MW, Peto J, Dos-Santos-Silva I, Sawyer EJ, Tomlinson I, Burwinkel B, Marme F, Guénel P, Truong T, Bojesen SE, Nordestgaard BG, González-Neira A, Benitez J, Neuhausen SL, Brenner H, Dieffenbach AK, Meindl A, Schmutzler RK, Brauch H; GENICA Network, Nevanlinna H, Khan S, Matsuo K, Ito H, Dörk T, Bogdanova NV, Lindblom A, Margolin S, Mannermaa A, Kosma VM; kConFab Investigators; Australian Ovarian Cancer Study Group, Wu AH, Van Den Berg D, Lambrechts D, Wildiers H, Chang-Claude J, Rudolph A, Radice P, Peterlongo P, Couch FJ, Olson JE, Giles GG, Milne RL, Haiman CA, Henderson BE, Dumont M, Teo SH, Wong TY, Kristensen V, Zheng W, Long J, Winqvist R, Pylkäs K, Andrulis IL, Knight JA, Devilee P, Seynaeve C, García-Closas M, Figueroa J, Klevebring D, Czene K, Hooning MJ, van den Ouweland AM, Darabi H, Shu XO, Gao YT, Cox A, Blot W, Signorello LB, Shah M, Kang D, Choi JY, Hartman M, Miao H, Hamann U, Jakubowska A, Lubinski J, Sangrajrang S, McKay J, Toland AE, Yannoukakos D, Shen CY, Wu PE, Swerdlow A, Orr N, Simard J, Pharoah PD, Dunning AM, Chenevix-Trench G, Hall P, Bandera E, Amos C, Ambrosone C, Easton DF, Cole MD.

Hum Mol Genet. 2016 Sep 1;25(17):3863-3876. doi: 10.1093/hmg/ddw223. Epub 2016 Jul 11.

14.

Strategically targeting MYC in cancer.

Posternak V, Cole MD.

F1000Res. 2016 Mar 29;5. pii: F1000 Faculty Rev-408. doi: 10.12688/f1000research.7879.1. eCollection 2016. Review.

15.

Ruptured Sinus of Valsalva Aneurysm into the Left Atrium with Multiple Fistulous Communications: A Rare Cause of Heart Failure.

Agrawal Y, Chandrashekhar R, Pratt JW, Cole MD, Kamath S, Kalavakunta JK.

Case Rep Cardiol. 2015;2015:627946. doi: 10.1155/2015/627946. Epub 2015 Dec 27.

16.

Retroviruses hijack chromatin loops to drive oncogene expression and highlight the chromatin architecture around proto-oncogenic loci.

Pattison JM, Wright JB, Cole MD.

PLoS One. 2015 Mar 23;10(3):e0120256. doi: 10.1371/journal.pone.0120256. eCollection 2015.

17.

MYC association with cancer risk and a new model of MYC-mediated repression.

Cole MD.

Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a014316. doi: 10.1101/cshperspect.a014316. Review.

18.

Surgical and procedural skills training at medical school - a national review.

Davis CR, Toll EC, Bates AS, Cole MD, Smith FC.

Int J Surg. 2014;12(8):877-82. doi: 10.1016/j.ijsu.2014.05.069. Epub 2014 Jun 5.

19.

Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility.

Hu T, Pan Q, Andrew AS, Langer JM, Cole MD, Tomlinson CR, Karagas MR, Moore JH.

BioData Min. 2014 Apr 11;7(1):5. doi: 10.1186/1756-0381-7-5.

20.

Drug facilitated sexual assault: detection and stability of benzodiazepines in spiked drinks using gas chromatography-mass spectrometry.

Gautam L, Sharratt SD, Cole MD.

PLoS One. 2014 Feb 19;9(2):e89031. doi: 10.1371/journal.pone.0089031. eCollection 2014.

21.

Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis.

Cowling VH, Turner SA, Cole MD.

Oncogene. 2014 Jul 3;33(27):3519-27. doi: 10.1038/onc.2013.338. Epub 2013 Sep 9.

22.

Forensic Analysis of Cathinones.

Gautam L, Shanmuganathan A, Cole MD.

Forensic Sci Rev. 2013 Mar;25(1-2):47-64. Review.

PMID:
26226850
23.

Vibration arthrometry: a critical review.

Abbott SC, Cole MD.

Crit Rev Biomed Eng. 2013;41(3):223-42. Review.

PMID:
24579645
24.

MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.

Kaur M, Cole MD.

Cancer Res. 2013 Jan 15;73(2):695-705. doi: 10.1158/0008-5472.CAN-12-2522. Epub 2012 Nov 7.

25.

Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression.

Cowper-Sal lari R, Zhang X, Wright JB, Bailey SD, Cole MD, Eeckhoute J, Moore JH, Lupien M.

Nat Genet. 2012 Nov;44(11):1191-8. doi: 10.1038/ng.2416. Epub 2012 Sep 23.

26.

Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells.

Doe MR, Ascano JM, Kaur M, Cole MD.

Cancer Res. 2012 Feb 15;72(4):949-57. doi: 10.1158/0008-5472.CAN-11-2371. Epub 2011 Dec 20.

27.

Distal interleukin-1β (IL-1β) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression.

Schmucker AC, Wright JB, Cole MD, Brinckerhoff CE.

J Biol Chem. 2012 Jan 6;287(2):1189-97. doi: 10.1074/jbc.M111.264077. Epub 2011 Nov 18.

28.

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.

Savino M, Annibali D, Carucci N, Favuzzi E, Cole MD, Evan GI, Soucek L, Nasi S.

PLoS One. 2011;6(7):e22284. doi: 10.1371/journal.pone.0022284. Epub 2011 Jul 21.

29.

Layers of epistasis: genome-wide regulatory networks and network approaches to genome-wide association studies.

Cowper-Sal lari R, Cole MD, Karagas MR, Lupien M, Moore JH.

Wiley Interdiscip Rev Syst Biol Med. 2011 Sep-Oct;3(5):513-26. doi: 10.1002/wsbm.132. Epub 2010 Dec 31. Review.

30.

Myc Regulation of mRNA Cap Methylation.

Cowling VH, Cole MD.

Genes Cancer. 2010 Jun;1(6):576-579.

31.

Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells.

Choi SH, Wright JB, Gerber SA, Cole MD.

Genes Dev. 2010 Jun 15;24(12):1236-41. doi: 10.1101/gad.1920310.

32.

Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.

Wright JB, Brown SJ, Cole MD.

Mol Cell Biol. 2010 Mar;30(6):1411-20. doi: 10.1128/MCB.01384-09. Epub 2010 Jan 11.

33.

Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex.

Cai Y, Jin J, Swanson SK, Cole MD, Choi SH, Florens L, Washburn MP, Conaway JW, Conaway RC.

J Biol Chem. 2010 Feb 12;285(7):4268-72. doi: 10.1074/jbc.C109.087981. Epub 2009 Dec 14.

34.

A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.

Chandriani S, Frengen E, Cowling VH, Pendergrass SA, Perou CM, Whitfield ML, Cole MD.

PLoS One. 2009 Aug 19;4(8):e6693. doi: 10.1371/journal.pone.0006693.

35.

Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors.

Cole MD, Cowling VH.

Oncogene. 2009 Mar 5;28(9):1169-75. doi: 10.1038/onc.2008.463. Epub 2009 Jan 12.

36.

Evolution of the holozoan ribosome biogenesis regulon.

Brown SJ, Cole MD, Erives AJ.

BMC Genomics. 2008 Sep 24;9:442. doi: 10.1186/1471-2164-9-442.

37.

Transcription-independent functions of MYC: regulation of translation and DNA replication.

Cole MD, Cowling VH.

Nat Rev Mol Cell Biol. 2008 Oct;9(10):810-5. doi: 10.1038/nrm2467. Epub 2008 Aug 13. Review.

38.

Reptin and Pontin function antagonistically with PcG and TrxG complexes to mediate Hox gene control.

Diop SB, Bertaux K, Vasanthi D, Sarkeshik A, Goirand B, Aragnol D, Tolwinski NS, Cole MD, Pradel J, Yates JR 3rd, Mishra RK, Graba Y, Saurin AJ.

EMBO Rep. 2008 Mar;9(3):260-6. doi: 10.1038/embor.2008.8. Epub 2008 Feb 8.

39.

Displacement of nuclear fragments into the vitreous complicating phacoemulsification surgery in the UK: incidence and risk factors.

Mahmood S, von Lany H, Cole MD, Charles SJ, James CR, Foot B, Gouws P, Shaw S.

Br J Ophthalmol. 2008 Apr;92(4):488-92. Epub 2007 Oct 26.

PMID:
17965101
40.

Displacement of nuclear fragments into the vitreous complicating phacoemulsification surgery in the UK: clinical features, outcomes and management.

von Lany H, Mahmood S, James CR, Cole MD, Charles SJ, Foot B, Gouws P, Shaw S.

Br J Ophthalmol. 2008 Apr;92(4):493-5. Epub 2007 Oct 25.

PMID:
17962391
41.

Turning the tables: Myc activates Wnt in breast cancer.

Cowling VH, Cole MD.

Cell Cycle. 2007 Nov 1;6(21):2625-7. Epub 2007 Aug 13. Review.

PMID:
17726380
42.
43.
44.

c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1.

Cowling VH, D'Cruz CM, Chodosh LA, Cole MD.

Mol Cell Biol. 2007 Jul;27(14):5135-46. Epub 2007 May 7.

45.

HATs off to capping: a new mechanism for Myc.

Cowling VH, Cole MD.

Cell Cycle. 2007 Apr 15;6(8):907-9. Epub 2007 Apr 8.

PMID:
17404507
47.

Development of a harmonised method for the profiling of amphetamines V: Determination of the variability of the optimised method.

Lock E, Aalberg L, Andersson K, Dahlén J, Cole MD, Finnon Y, Huizer H, Jalava K, Kaa E, Lopes A, Poortman-van der Meer A, Sippola E.

Forensic Sci Int. 2007 Jun 14;169(1):77-85. Epub 2006 Dec 18.

PMID:
17178203
48.

Development of a harmonised method for the profiling of amphetamines: III. Development of the gas chromatographic method.

Andersson K, Jalava K, Lock E, Finnon Y, Huizer H, Kaa E, Lopes A, Poortman-van der Meer A, Cole MD, Dahlén J, Sippola E.

Forensic Sci Int. 2007 Jun 14;169(1):50-63. Epub 2006 Dec 15.

PMID:
17174497
49.

E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.

Cowling VH, Cole MD.

Oncogene. 2007 May 24;26(24):3582-6. Epub 2006 Dec 4.

PMID:
17146437
50.

Development of a harmonised method for the profiling of amphetamines: IV. Optimisation of sample preparation.

Andersson K, Jalava K, Lock E, Huizer H, Kaa E, Lopes A, Poortman-van der Meer A, Cole MD, Dahlén J, Sippola E.

Forensic Sci Int. 2007 Jun 14;169(1):64-76. Epub 2006 Nov 28.

PMID:
17134863

Supplemental Content

Support Center